SCHEMBL20748151

SCHEMBL20748151

CCC(c1cccc2ncccc12)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.38
LMNA P02545 3/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR2C P28335 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2B P41595 1/20 0.36
CYP3A4 P08684 1/20 0.36
MPO P05164 1/20 0.36
CYP19A1 P11511 1/20 0.35
TBXAS1 P24557 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14464030 0.83 MAPT (0.45) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL20759412 0.83 MAPT (0.45) MAPTKDM4EMEN1KMT2AALDH1A1
Butane SCHEMBL827167 0.80 MAPT (0.45) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL15810094 0.80 MAPT (0.45) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL23641430 0.80 MAPT (0.48) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL30994907 0.79 MAPT (0.52) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL84436 0.79 MAPT (0.52) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL6847984 0.79 KDM4E (0.44) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL27335432 0.79 MAPT (0.44) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL21240895 0.77 KDM4E (0.42) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208011-B2 Benzothiophene estrogen receptor modulators G1 THERAPEUTICS, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208011-B2 Benzothiophene estrogen receptor modulators ESR1, GPER1, ESR2 MAPT 471/4885KDM4E 963/4885MEN1 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.